O
AVNR

OppenheimerFunds’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

OppenheimerFunds’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-32,549
Closed -$552K – 1003
2014
Q4 		$552K Sell
32,549
-1,967,451
-98% -$27.7M ﹤0.01% 892
2014
Q3 		$23.8M Buy
+2,000,000
New +$13.7M 0.03% 526

OppenheimerFunds's AVNR Position: Q1 2015 in Review

OppenheimerFunds sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 32,549 shares — an estimated $552K sold.

OppenheimerFunds first reported a position in AVNR in Q3 2014 and held it in 2 quarters. The position peaked at $23.8M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • OppenheimerFunds reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • OppenheimerFunds sold 32,549 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $552K.
  • OppenheimerFunds first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2014 and held it in 2 quarters.
  • OppenheimerFunds's AVANIR PHARMACEUTICALS, INC CL A position peaked at $23.8M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on OppenheimerFunds's 13F filing for Q1 2015, filed 15 May 2015.